In Reply to Gerber et al

International Journal of Radiation Oncology, Biology, Physics, Volume 99, Issue 2, 2017 Oct 1 | Rahimi, Asal, MD; Timmerman, Robert, MD
To the Editor: We appreciate this review (1) of our phase 1 stereotactic partial breast irradiation (2) (S-PBI) clinical trial. As the authors outlined, the previously assumed alpha/beta for breast cancer has fallen within the range of 3 to 4 Gy, ...

http://ift.tt/2wyr0N7